Literature DB >> 9923765

Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.

M Tagliati1, J Grinnell, J Godbold, D M Simpson.   

Abstract

OBJECTIVE: To determine the effects of immunodeficiency, nutritional status, and concurrent systemic disease on peripheral nerve function in acquired immunodeficiency syndrome.
DESIGN: Survey of subjects infected with human immunodeficiency virus (HIV), recruited as part of a prospective study of neuromuscular complications of HIV infection.
SETTING: A neuro-acquired immunodeficiency syndrome outpatient clinic in a university medical center. PATIENTS: A consecutive sample of 251 HIV-infected individuals. Primary care providers referred subjects to the study for evaluation of neurologic symptoms or for prospective neurologic assessment. MAIN OUTCOME MEASURES: Standardized history and neurologic examination, laboratory tests (complete blood cell count, serum albumin level, vitamin B12 level, and T-lymphocyte subsets), and electrophysiologic testing of sural, tibial, and ulnar nerves.
RESULTS: The most frequent neurologic diagnosis was distal symmetrical polyneuropathy (DSP) (38%). The most common clinical features were nonpainful paresthesias (71%), abnormalities of pain and temperature perception (71%), and reduced or absent ankle reflexes (66%). Patients with DSP were significantly older (P=.009), and had lower CD4 lymphocyte cell counts (P=.004) and lower hemoglobin levels (P=.004) than those without DSP. Deterioration of values on nerve conduction studies, irrespective of the clinical diagnosis of DSP, was significantly correlated with low CD4 counts, aging, abnormal serum albumin and hemoglobin levels, and weight loss. Most of these factors co-correlated, and, with the exception of age, no single variable significantly accounted for changes in results of nerve conduction studies when the influence of other factors was eliminated.
CONCLUSION: The combination of several factors, including age, immunosuppression, nutritional status, and chronic disease, contributes to distal peripheral nerve dysfunction in HIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 9923765     DOI: 10.1001/archneur.56.1.84

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  38 in total

1.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

Authors:  Ronald J Ellis; Debralee Rosario; David B Clifford; Justin C McArthur; David Simpson; Terry Alexander; Benjamin B Gelman; Florin Vaida; Ann Collier; Christina M Marra; Beau Ances; J Hampton Atkinson; Robert H Dworkin; Susan Morgello; Igor Grant
Journal:  Arch Neurol       Date:  2010-05

Review 2.  HIV-associated sensory neuropathy: risk factors and genetics.

Authors:  Peter R Kamerman; Antonia L Wadley; Catherine L Cherry
Journal:  Curr Pain Headache Rep       Date:  2012-06

3.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Authors:  Asha R Kallianpur; Todd Hulgan
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

4.  Incident neuropathy in HIV-infected patients on HAART.

Authors:  Beau K Nakamoto; Aaron McMurtray; James Davis; Victor Valcour; Michael R Watters; Bruce Shiramizu; Dominic C Chow; Kalpana Kallianpur; Cecilia M Shikuma
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

5.  Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV.

Authors:  Zaza Katsarava; Ozgüt Yaldizli; Christina Voulkoudis; Hans-Christoph Diener; Helger Kaube; Matthias Maschke
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

Review 6.  Update of HIV-Associated Sensory Neuropathies.

Authors:  Angela Aziz-Donnelly; Taylor B Harrison
Journal:  Curr Treat Options Neurol       Date:  2017-08-31       Impact factor: 3.598

Review 7.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

8.  HIV neuropathy: an in vivo confocal microscopic study.

Authors:  Jorge L Almodovar; Giovanni Schifitto; Michael P McDermott; Michele Ferguson; David N Herrmann
Journal:  J Neurovirol       Date:  2012-10-16       Impact factor: 2.643

Review 9.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study.

Authors:  Alaka K Deshpande; Mrinal M Patnaik
Journal:  J Int AIDS Soc       Date:  2005-10-04       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.